Miltefos 10 10 mg Capsule

    Miltefos 10 10 mg

    0/5 (0) Ratings

    Generic: Miltefosine

    Category: Capsule

    Manufacturer: Popular Pharmaceuticals Ltd.

    Unclassified — prescription required · Upload a prescription at checkout. Pharmacist approval is required before preparation.

    Currently unavailable to order.

    Indications

    Uses of Miltefos 10: - Kala-azar Visceral leishmaniasis, Mycosis fungoides, Skin metastases of breast cancer Pregnancy, lactation, concurrent radiation therapy.

    Dosage and Administration

    How to use Miltefosine: Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it. Miltefosine is to be taken with food. Adult Dose: Adult : PO Visceral Leishmaniasis 100-150 mg/day for 28 days. Child Dose: Child: PO 2.5 mg/kg/day bid >12 y: 30–44 kg: 100 mg/day bid >45 kg: 150 mg/day tid

    Interaction

    Miltefosine did not inhibit human cytochrome P450 enzymes in vitro. Miltefosine did not induce cytochrome 3A activity in rats.

    Contraindications

    Pregnancy, lactation, concurrent radiation therapy.

    Side Effects

    Common - Headache - Nausea - Itching - Sleepiness - Decreased appetite - Abdominal pain - Diarrhea - Vomiting - Dizziness - Increased creatinine level in blood - Increased liver enzymes >10% Visceral leishmaniasis Increased transaminases, <3 x ULN (94%),Decreased platelets <150,000 (62%),Vomiting (37.8%),Decreased appetite (23.1%),Diarrhea (20.4%) 1-10% Visceral leishmaniasis Increased serum creatinine, >1.5 x baseline (10%),Asthenia (6.3%),Increased transaminases, 3-5 x ULN (6%),Decreased platelets <50,000 (2.4%)

    Precautions And Warnings

    Precaution: Metastases grown over breast implants. Increased serum creatinine, ALT, AST, bilirubin reported; monitor. Thrombocytopenia reported; monitor platelets Stevens-Johnson syndrome reported; discontinue if an exfoliative or bullous rash occurs Lactation: Unknown if distributed in human breast milk; avoid breastfeeding during therapy and for 5 months following therapy

    Storage Conditions

    Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

    Drug Classes

    Leishmaniacides

    Mode of Action

    Miltefosine is a phospholipid derivative thought to work by disrupting cell-membrane function.

    Pregnancy Category

    Pregnancy: Miltefosine should not be used during pregnancy. Obtain a urine or serum pregnancy test in females of reproductive potential prior to prescribing.Nursing Mothers: Discontinue drug or nursing depending on the importance of drug to the mother. Avoid breastfeeding for 5 months after Miltefosine therapy.Females and Males of Reproductive Potential: Advise females to use effective contraception during therapy and for 5 months after therapy. Advise patients of reproductive toxicities in animals, and that the potential for impaired fertility in humans has not been adequately evaluated

    Rating & Reviews

    0.00/5
    0 Ratings
    0%0
    0%0
    0%0
    0%0
    0%0

    Ratings reflect purchase experience: item condition when rated, otherwise pharmacy service.

    No reviews found.

    Customer photo of the received medicine or packaging
    Profile avater

    Samm Care

    Cart

    Loading your cart…